Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05655845Unknown

Risk Factors for Bowel Dysfunction at Preschool and Early Childhood Age in Children With Hirschsprung Disease

Role: lead

NCT05909033Unknown

Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure

Role: lead

NCT04464057Not ApplicableCompleted

Safety and Effectiveness of Early Feeding After Bowel Anastomosis in Neonates or Infants

Role: lead

NCT05461924Unknown

The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease

Role: lead

NCT05593861Completed

Assessment of Enhanced Recovery After Surgery Implementation at Pediatric Surgery Practices in Mainland China

Role: lead

NCT02776176Not ApplicableUnknown

Enhanced Recovery After Surgery In Hirschsprung Disease

Role: lead

All 6 trials loaded